NASDAQ:ONCS - OncoSec Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding OncoSec Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.86 -0.01 (-0.53 %) (As of 01/24/2020 01:13 PM ET) Add Compare Today's Range$1.87Now: $1.87▼$1.9850-Day Range$1.72MA: $1.97▼$2.4252-Week Range$1.60Now: $1.87▼$9.50Volume45,718 shsAverage Volume62,293 shsMarket Capitalization$19.97 millionP/E RatioN/ADividend YieldN/ABeta2.17 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email OncoSec Medical Incorporated, a biotechnology company, focuses on the development of cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. Its lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ONCS Previous Symbol CUSIPN/A CIK1444307 Webhttp://www.oncosec.com/ Phone855-662-6732Debt Debt-to-Equity Ratio0.04 Current Ratio2.79 Quick Ratio2.79Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.28 per share Price / Book0.82Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-30,280,000.00 Net MarginsN/A Return on Equity-152.00% Return on Assets-115.56%Miscellaneous Employees33 Outstanding Shares10,710,000Market Cap$19.97 million Next Earnings Date1/24/2020 (Estimated) OptionableNot Optionable Receive ONCS News and Ratings via Email Sign-up to receive the latest news and ratings for ONCS and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:ONCS Rates by TradingView OncoSec Medical (NASDAQ:ONCS) Frequently Asked Questions What is OncoSec Medical's stock symbol? OncoSec Medical trades on the NASDAQ under the ticker symbol "ONCS." When did OncoSec Medical's stock split? How did OncoSec Medical's stock split work? Shares of OncoSec Medical reverse split before market open on Tuesday, May 21st 2019. The 1-10 reverse split was announced on Monday, May 20th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 20th 2019. An investor that had 100 shares of OncoSec Medical stock prior to the reverse split would have 10 shares after the split. How were OncoSec Medical's earnings last quarter? OncoSec Medical Inc (NASDAQ:ONCS) released its earnings results on Wednesday, October, 25th. The biotechnology company reported ($2.80) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($2.30) by $0.50. View OncoSec Medical's Earnings History. When is OncoSec Medical's next earnings date? OncoSec Medical is scheduled to release their next quarterly earnings announcement on Friday, January 24th 2020. View Earnings Estimates for OncoSec Medical. What price target have analysts set for ONCS? 1 brokers have issued 12 month price objectives for OncoSec Medical's stock. Their forecasts range from $6.00 to $6.00. On average, they expect OncoSec Medical's stock price to reach $6.00 in the next year. This suggests a possible upside of 221.7% from the stock's current price. View Analyst Price Targets for OncoSec Medical. What is the consensus analysts' recommendation for OncoSec Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OncoSec Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OncoSec Medical. What are Wall Street analysts saying about OncoSec Medical stock? Here are some recent quotes from research analysts about OncoSec Medical stock: 1. According to Zacks Investment Research, "OncoSec Medical Incorporated is a biomedical company engaged in the designing, development and commercialization of therapeutic oncology products. It also develops novel OMS ElectroOncology therapies and OncoSec Medical System for the treatment of solid tumors. OncoSec Medical Incorporated is based in San Diego, California. " (12/31/2019) 2. Maxim Group analysts commented, "OncoSec announced a collaboration agreement with Dana-Farber Cancer Institute whereby OncoSec acquired an exclusive option to licensing rights to CAR-T candidates and associated IP from research being conducted the Marasco Laboratory." (6/28/2019) Has OncoSec Medical been receiving favorable news coverage? Press coverage about ONCS stock has been trending somewhat negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. OncoSec Medical earned a news sentiment score of -1.9 on InfoTrie's scale. They also gave headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for OncoSec Medical. Are investors shorting OncoSec Medical? OncoSec Medical saw a decline in short interest in the month of December. As of December 31st, there was short interest totalling 280,000 shares, a decline of 13.0% from the December 15th total of 321,800 shares. Based on an average daily volume of 274,700 shares, the days-to-cover ratio is currently 1.0 days. Currently, 3.1% of the company's stock are short sold. View OncoSec Medical's Current Options Chain. Who are some of OncoSec Medical's key competitors? Some companies that are related to OncoSec Medical include Trevena (TRVN), ESSA Pharma (EPIX), Catalyst Biosciences (CBIO), ASLAN PHARMACEU/ADR (ASLN), IMMUTEP LTD/S (IMMP), Vaccinex (VCNX), Catabasis Pharmaceuticals (CATB), Cumberland Pharmaceuticals (CPIX), Checkpoint Therapeutics (CKPT), CTI BioPharma (CTIC), Eyenovia (EYEN), NewLink Genetics (NLNK), Tiziana Life Sciences (TLSA), AgeX Therapeutics (AGE) and CNS Pharmaceuticals (CNSP). What other stocks do shareholders of OncoSec Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other OncoSec Medical investors own include Cytokinetics (CYTK), XOMA (XOMA), Inovio Pharmaceuticals (INO), Anavex Life Sciences (AVXL), Walt Disney (DIS), Idera Pharmaceuticals (IDRA), Rexahn Pharmaceuticals (REXN), Catalyst Pharmaceuticals (CPRX), Arena Pharmaceuticals (ARNA) and Synergy Pharmaceuticals (SGYP). Who are OncoSec Medical's key executives? OncoSec Medical's management team includes the folowing people: Dr. Avtar S. Dhillon, Co-Founder & Chairman (Age 57)Mr. Daniel J. O'Connor J.D., Pres, CEO & Director (Age 55)Mr. Punit S. Dhillon B.A., BA, Co-Founder & Director (Age 39)Ms. Sara M. Bonstein, CFO, COO & Company Sec. (Age 38)Dr. Christopher G. Twitty Ph.D., Chief Scientific Officer How do I buy shares of OncoSec Medical? Shares of ONCS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is OncoSec Medical's stock price today? One share of ONCS stock can currently be purchased for approximately $1.87. How big of a company is OncoSec Medical? OncoSec Medical has a market capitalization of $19.97 million. OncoSec Medical employs 33 workers across the globe.View Additional Information About OncoSec Medical. What is OncoSec Medical's official website? The official website for OncoSec Medical is http://www.oncosec.com/. How can I contact OncoSec Medical? OncoSec Medical's mailing address is 3565 GENERAL ATOMICS COURT, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at 855-662-6732 or via email at [email protected] MarketBeat Community Rating for OncoSec Medical (NASDAQ ONCS)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 289 (Vote Outperform)Underperform Votes: 359 (Vote Underperform)Total Votes: 648MarketBeat's community ratings are surveys of what our community members think about OncoSec Medical and other stocks. Vote "Outperform" if you believe ONCS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ONCS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/24/2020 by MarketBeat.com StaffFeatured Article: How to Invest in an Index Fund
